What is the CGEM stock price prediction for next 2 weeks?

According to our price prediction algorithm,Cullinan Therapeutics, Inc. (CGEM) price will be around $19.13 in the next 2 weeks. This means it will increase by 5.9390919158361095 from the last closing price. This prediction may vary from other time period filters for CGEM stock.

What can be the highest Possible price of CGEM stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CGEM can achieve the highest price of $20.78 which is 15.040183758381733 higher than last closing price. This prediction may vary from other time period filters for CGEM stock.

What can be the lowest Possible price of CGEM stock in next 2 weeks?

As per the forecast and algorithmic analysis, CGEM stock price can be as low as $17.26 which is -4.430875480695208 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for CGEM stock.

Will CGEM stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that CGEM stock will gain5.9390919158361095 in the next 2 weeks. This prediction may vary from other time period filters for CGEM stock.

What is CGEM stock last closing price?

Last closing price of CGEM stock was $18.06.

What is CGEM stock price prediction?

CGEM stock price prediction means predicting the future closing prices of CGEM stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CGEM stock in a certain time period.

How we predict CGEM stock future prices?

If you are searching for CGEM stock forecast, analysis or price prediction, then you might be wondering what Cullinan Therapeutics, Inc. (CGEM) will do in the future. Our CGEM price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CGEM price prediction will likely answer most of your questions.

How frequent we update CGEM stock predictions?

We are updating the forecasts for the CGEM stock on daily basis.

Is using ML forecasting for CGEM stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CGEM stock same for all the time periods?

No, the prediction for CGEM stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Cullinan Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$18.06-2.01%Since 2 Weeks

Predicted Price$19.135.94%For 2 Weeks

Upper Predicted Price$20.7815.04%For 2 Weeks

Lower Predicted Price$17.26-4.43%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CGEM will rise by +5.94% over the next 2 Weeks and hit $19.13 by Tuesday, August 4, 2026. In that time frame, CGEM's share price is expected to range between $17.26 and $20.78.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 4, 2026	17.26	19.13	20.78
Aug 3, 2026	17.59	19.30	20.99
Jul 31, 2026	17.32	19.07	20.79
Jul 30, 2026	16.71	18.47	20.23
Jul 29, 2026	16.72	18.40	20.10
Jul 28, 2026	16.64	18.42	20.07
Jul 27, 2026	16.75	18.58	20.37
Jul 24, 2026	16.59	18.35	20.12
Jul 23, 2026	15.98	17.75	19.42
Jul 22, 2026	15.90	17.69	19.40

CGEM shares fell -1.08% in Wednesday, July 22, 2026's trading session, dropping from a previous close of $18.06 to move at $17.87. The stock demonstrated notable intraday movement (see CGEM's key stats for a full breakdown), fluctuating between $17.71 and $18.21, a +2.82% trading range. While recent weeks have seen some volatility, CGEM has managed to secure a -3.07% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 428.05K shares changing hands, 44.29K fewer than the previous session. This amounted to $7.65M in total market activity.

Will CGEM Continue Its Upward Trend?

According to analyst ratings and projections for CGEM, Cullinan Therapeutics, Inc. shares are anticipated to increase by +14.01%, potentially reaching $20.78 per share by August 4, 2026. Short-term technical indicators currently suggest a neutral sentiment for CGEM. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the CGEM stock forecast, now is a good time to buy CGEM stock because its current trading price is -6.63% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CGEM covering social and institutional perspectives.

CGEM Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CGEM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 54.84% to 56.59%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 56.03%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.17%, maintains a neutral outlook for the long term. Insights into CGEM's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Cullinan Therapeutics Short-Term Forecasts

CGEM Forecast For Next 5 Days

Our algorithm anticipates Cullinan Therapeutics (CGEM) stock could hit $19.43 by Jul 29, 2026. This represents a +8.73% rise from today's price, following a +2.45% change over the past five days.

CGEM Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Cullinan Therapeutics, Inc. (CGEM) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $18.70, which would mean a +4.67% increase from the current price of $17.87. Projections for this period range from a high of $21.57 to a low of $15.88.

CGEM Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Cullinan Therapeutics's price over the next three months point to a drop. CGEM stock is expected to peak at $20.61 on Oct 21, 2026 after potentially dipping to $14.61 on Oct 12, 2026. On average, CGEM is likely to trade around $17.70 in the coming 90 days.

Cullinan Therapeutics Stock Forecast 2025

Based on our predictive models, Cullinan Therapeutics (CGEM) is expected to trade between $14.61 and $20.84 throughout 2026. This would result in an average price of $17.82, potentially offering investors a -0.25% return from current levels.

Cullinan Therapeutics, Inc. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Cullinan Therapeutics, Inc. (CGEM) is positioned to show a strong performance in July 2026. The price is predicted to move between $15.76 and $19.61, settling at an average of $17.76. This could translate to a -0.59% loss.

August 2026

Based on current market signals, Cullinan Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $15.12 to $19.68, with a likely average price of $17.54. Investors could expect a potential return of -1.82%.

September 2026

Our predictive algorithms indicate Cullinan Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $15.09–$19.90, with an average target of $17.52. This represents a cautious outlook and a possible loss of -1.93%.

October 2026

Analyzing established trends, Cullinan Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $14.61 and $20.61, averaging around $18.20. This suggests a +1.88% gain from current levels.

November 2026

Market indicators suggest Cullinan Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $15.76 to $20.84, with a midpoint forecast of $18.21. The stock might deliver a +1.93% gain.

December 2026

Forecasting for December 2026, models estimate that Cullinan Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $15.57 and $19.73, averaging $17.64. This signals a cautious trajectory with potential returns around -1.26%.

January 2027

According to our latest forecast models, Cullinan Therapeutics, Inc. (CGEM) is positioned to show a strong performance in January 2027. The price is predicted to move between $14.95 and $19.61, settling at an average of $17.28. This could translate to a -3.27% loss.

February 2027

Based on current market signals, Cullinan Therapeutics, Inc. is projected to trend february 2027. We forecast a trading range from $14.93 to $19.62, with a likely average price of $17.37. Investors could expect a potential return of -2.77%.

March 2027

Our predictive algorithms indicate Cullinan Therapeutics, Inc. stock may see a shift in March 2027. The expected range spans $15.74–$20.09, with an average target of $18.07. This represents a positive outlook and a possible gain of +1.15%.

April 2027

Analyzing established trends, Cullinan Therapeutics, Inc. looks set to move in April 2027. Projections place the stock between $15.59 and $20.70, averaging around $17.98. This suggests a +0.64% gain from current levels.

May 2027

Market indicators suggest Cullinan Therapeutics, Inc. could experience notable changes during May 2027. Prices could fluctuate within $15.32 to $19.50, with a midpoint forecast of $17.42. The stock might deliver a -2.49% loss.

June 2027

Forecasting for June 2027, models estimate that Cullinan Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $14.67 and $19.33, averaging $17.06. This signals a cautious trajectory with potential returns around -4.51%.

July 2027

According to our latest forecast models, Cullinan Therapeutics, Inc. (CGEM) is positioned to show a strong performance in July 2027. The price is predicted to move between $14.76 and $19.77, settling at an average of $17.12. This could translate to a -4.17% loss.

CGEM's history of dividends and stock splits also plays a role in long-term investor confidence.